Hydralazine

HYDRAPRES^® is indicated in the treatment of:

• Essential hypertension
• Congestive heart failure

HYDRAPRES^® administered as parenteral injection. It is supplied in 20 mg lyophilised powder (5 ampoule per box) or 50 mg and 25 mg tablets (30 tablets per box)